Psoriatic arthritis, methotrexate and the liver--are rheumatologists putting their patients at risk?
Authors:
Open Access
- 25 April 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 47 (7) , 939-941
Abstract
It seems hard to believe that in the early 1990s MTX use by a respected group of UK rheumatologists in nine hospitals only represented 3% of all DMARDs used for a cohort of patients presenting with early RA [1]. It is now the most widely used DMARD, not only for RA, but is effective for both psoriasis and PsA [2, 3]. It has also become our principal anchor drug in combination therapy, including the anti-TNF agents, where recent data suggests that their combination is our best treatment option yet in RA [4]. As a cheap, effective and usually well-tolerated drug it is not surprising that prescribing it worldwide has continued to rise exponentially and that the patients may be on it commonly for >5 yrs.Keywords
This publication has 30 references indexed in Scilit:
- Methotrexate and Hepatic Toxicity in??Rheumatoid Arthritis and Psoriatic ArthritisClinical Drug Investigation, 2006
- Methotrexate for psoriasis: current European practice. A postal surveyJournal of the European Academy of Dermatology and Venereology, 2005
- A randomized controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: Ten-year resultsHepatology, 2004
- Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trialThe Lancet, 2004
- Methotrexate and mortality in patients with rheumatoid arthritis: a prospective studyThe Lancet, 2002
- Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: A forty-eight-week, multicenter, randomized, double-blind, placebo-controlled studyArthritis & Rheumatism, 2001
- How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow‐up in 732 patients from the Early RA Study (ERAS)Rheumatology, 2000
- The changing face of rheumatoid arthritis therapy: Results of serial surveysArthritis & Rheumatism, 2000
- Methotrexate in psoriasis: Consensus conferenceJournal of the American Academy of Dermatology, 1998
- Long‐Term Prospective Study of Methotrexate in the Treatment of Rheumatoid ArthritisArthritis & Rheumatism, 1992